Time-dependent ROC curve estimation for interval-censored data. 2022

Kassu Mehari Beyene, and Anouar El Ghouch
ISBA, UCLouvain, Louvain la Neuve, Belgium.

The receiver-operating characteristic (ROC) curve is the most popular graphical method for evaluating the classification accuracy of a diagnostic marker. In time-to-event studies, the subject's event status is time-dependent, and hence, time-dependent extensions of ROC curve have been proposed. However, in practice, the calculation of this curve is not straightforward due to the presence of censoring that may be of different types. Existing methods focus on the more standard and simple case of right-censoring and neglect the general case of mixed interval-censored data that may involve left-, right-, and interval-censored observations. In this context, we propose and study a new time-dependent ROC curve estimator. We also consider some summary measures (area under the ROC curve and Youden index) traditionally associated with ROC as well as the Youden-based cutoff estimation method. The proposed method uses available data very efficiently. To this end, the unknown status (positive or negative) of censored subjects are estimated from the data via the estimation of the conditional survival function given the marker. For that, we investigate both model-based and nonparametric approaches. We also provide variance estimates and confidence intervals using Bootstrap. A simulation study is conducted to investigate the finite sample behavior of the proposed methods and to compare their performance with a competitor. Globally, we observed better finite sample performances for the proposed estimators. Finally, we illustrate the methods using two data sets one from a hypobaric decompression sickness study and the other from an oral health study. The proposed methods are implemented in the R package cenROC.

UI MeSH Term Description Entries
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012372 ROC Curve A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli. ROC Analysis,Receiver Operating Characteristic,Analysis, ROC,Analyses, ROC,Characteristic, Receiver Operating,Characteristics, Receiver Operating,Curve, ROC,Curves, ROC,ROC Analyses,ROC Curves,Receiver Operating Characteristics
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D019540 Area Under Curve A statistical means of summarizing information from a series of measurements on one individual. It is frequently used in clinical pharmacology where the AUC from serum levels can be interpreted as the total uptake of whatever has been administered. As a plot of the concentration of a drug against time, after a single dose of medicine, producing a standard shape curve, it is a means of comparing the bioavailability of the same drug made by different companies. (From Winslade, Dictionary of Clinical Research, 1992) AUC,Area Under Curves,Curve, Area Under,Curves, Area Under,Under Curve, Area,Under Curves, Area

Related Publications

Kassu Mehari Beyene, and Anouar El Ghouch
August 1997, Gan to kagaku ryoho. Cancer & chemotherapy,
Kassu Mehari Beyene, and Anouar El Ghouch
June 2000, Biometrics,
Kassu Mehari Beyene, and Anouar El Ghouch
January 2018, Journal of biopharmaceutical statistics,
Kassu Mehari Beyene, and Anouar El Ghouch
March 2018, Biometrics,
Kassu Mehari Beyene, and Anouar El Ghouch
October 2006, Biostatistics (Oxford, England),
Kassu Mehari Beyene, and Anouar El Ghouch
March 2018, Research synthesis methods,
Kassu Mehari Beyene, and Anouar El Ghouch
March 2014, Biometrical journal. Biometrische Zeitschrift,
Kassu Mehari Beyene, and Anouar El Ghouch
November 2023, Statistics in medicine,
Kassu Mehari Beyene, and Anouar El Ghouch
January 1997, Lifetime data analysis,
Kassu Mehari Beyene, and Anouar El Ghouch
October 2004, Biostatistics (Oxford, England),
Copied contents to your clipboard!